|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| Pulmatrix Snags $14M, Embera Adds for $4.5 Addiction Drugs, Daktari Gets $1.2M, & More Boston-Area Life Sciences News | Erin Kutz | 08/19/11 | Boston | |
| Alkermes’ Anti-Addiction Drug, Key to Company Pipeline, Passes Early Test | Luke Timmerman | 10/13/09 | Boston | |
| Page 1 of 1 | ||||
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.